Eli Lilly Tells Fed. Circ. $177M Patent Loss Was Rightly Axed
Eli Lilly & Co. has urged the Federal Circuit to uphold a Massachusetts federal judge's decision that wiped out a $176.5 million verdict against it for infringing Teva migraine drug patents,...To view the full article, register now.
Already a subscriber? Click here to view full article